Form 4 for MRK Merck & Co.
Accepted 2022-11-07 00:00:00 ET · period of report 2022-11-03 · accession 0001127602-22-025018 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-11-07 | 2022-11-03+ | MRK | FRAZIER KENNETH C | Executive COB, Dir | S - Sale+OE | $98.66 | -470.0K | 721.0K | -39% | -$46.37M |
| DM | 2022-11-07 | 2022-11-03+ | MRK | FRAZIER KENNETH C | Executive COB, Dir | M - OptEx | $0.00 | +470.0K | 935.7K | +101% | $0 |
| DM | 2022-11-07 | 2022-11-03+ | MRK | FRAZIER KENNETH C | Executive COB, Dir | M - OptEx | $0.00 | -470.0K | 470.8K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-04 | S | D | 34,810 | $99.08 | 700,653.06 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.9800 to $99.2800, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. (F5) Holdings include shares acquired in dividend reinvestment transactions. |
| 2 | Common | Common Stock | 2022-11-04 | S | D | 200,190 | $98.53 | 735,463.06 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.9700 to $98.9700, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. |
| 3 | Common | Common Stock | 2022-11-03 | S | D | 20,383 | $99.09 | 700,653.06 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.0600 to $99.2000, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. |
| 4 | Common | Common Stock | 2022-11-03 | S | D | 214,617 | $98.68 | 721,036.06 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.0500 to $99.0500, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. |
| 5 | Common | Common Stock | 2022-11-03 | M | A | 235,000 | $0.00 | 935,653.06 | D | — | — | |
| 6 | Common | Common Stock | 2022-11-04 | M | A | 235,000 | $0.00 | 935,653.06 | D | — | — | |
| 7 | Derivative | Stock Option (Right to Buy) | 2022-11-04 | M | D | 235,000 | $0.00 | 235,769 | D | $53.06 · 2017-05-10 to 2026-05-09 | 235,000 Common Stock | (F7) The option became exercisable in equal installments on 5/10/2017, 5/10/2018 and 5/10/2019. |
| 8 | Derivative | Stock Option (Right to Buy) | 2022-11-03 | M | D | 235,000 | $0.00 | 470,769 | D | $53.06 · 2017-05-10 to 2026-05-09 | 235,000 Common Stock | (F7) The option became exercisable in equal installments on 5/10/2017, 5/10/2018 and 5/10/2019. |